ArticleAdvances in radiation oncology2026
Time Course and Determinants of Acute Dysgeusia in Patients Receiving Head and Neck Radiation Therapy.
Article in Advances in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Dysgeusia is a common toxicity experienced by patients with head and neck cancer (HNC) receiving radiation therapy (RT). In this study, we assessed the timescale of onset, progression, and recovery of dysgeusia using an objective measure. Methods and Materials: Patients receiving RT for HNC to ≥ 50 Gy were included in this prospective observational study. The Waterless Empirical Taste Test (WETT) was used to objectively measure dysgeusia for the 5 basic tastes: sweet, sour, salty, bitter, and umami. Patients were assessed at baseline (pre-RT), 2 and 4 weeks mid-treatment, end of treatment (EOT), and 12 weeks post-RT. Changes in scores at different time points relative to baseline scores were computed. The significance of trends over time was tested using linear regression. Associations of taste scores with clinical and dosimetric variables were tested using Pearson correlation. Results: Of the 50 patients who underwent baseline taste testing, 32 completed 12-week post-RT follow-up assessments. The most common primary tumor site was the oropharynx (66%). The median WETT scores were 20.7 at baseline, 16.2 at 2 weeks, 17.7 at 4 weeks, 17.1 at EOT, and 19 at follow-up. Baseline and EOT comparisons revealed a decline in total score (-17.3%), with the highest relative changes in umami (-62.5%) and salty (-30.9%). The relative total score change between baseline and follow-up was -8.2% ( Conclusions: This study confirms significant alterations in taste perception in patients with HNC during/after RT. Taste changes correlated with mean tongue and oral cavity doses. Future studies and longer follow-up are warranted to define dose-response relationships in dysgeusia.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.